High materiality9/10
Faeth Therapeutics assumed with a Buy at Lucid Capital
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises FTH target to 59; current price 39.24; price change since signal +1.4.
- UBS target $59; price $39.24; +$1.40 since signal.
Key facts
- 01
Target: $59
- 02
Posted price: $39.24
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.